Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran

Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran

Malak Rizk, Şükrü Tüzmen Molecular Biology and Genetics Program, Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University (EMU), Famagusta, North Cyprus, Turkey Abstract: RNA interference (RNAi) is a naturally existing endo...

Full description

Bibliographic Details
Main Authors: Rizk M, Tüzmen S
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
RNAi
TTR Gene
TTR amyloidosis
siRNA
gene silencing
Patisiran
Online Access:https://www.dovepress.com/update-on-the-clinical-utility-of-an-rna-interference-based-treatment--peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/update-on-the-clinical-utility-of-an-rna-interference-based-treatment--peer-reviewed-article-PGPM

Similar Items